Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study

The safety and efficacy of direct oral anticoagulants (DOACs) in intermediate-high risk pulmonary embolism (PE) are unknown. The aims of the present study were to describe outcomes of patients receiving early apixaban or rivaroxaban prescription rather than the recommended delayed prescription strat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Thrombosis research 2020-12, Vol.196, p.476-482
Hauptverfasser:	Chopard, Romain, Badoz, Marc, Eveno, Charly, Ecarnot, Fiona, Falvo, Nicolas, Kalbacher, Elsa, Capellier, Gilles, Guillon, Benoit, Schiele, François, Meneveau, Nicolas
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiac biomarkers Direct oral anticoagulant Life Sciences Pulmonary embolism Right ventricular dysfunction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!